Brian Flynn, MD
Urology · Aurora, CONPI 1063433514
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,349 of the $11,901 with a category attached, or 61.7%. 20 manufacturers reported payments, led by Uromedica, Incorporated at 59.6% of the total. Reporting peaked in 2023 at $6,281 and has fallen 54.3% since, to $2,873 in 2025.
Across 63 payments — averaging $188.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Uromedica, Incorporated$7K
- Teleflex LLC$957
- Boston Scientific$565
- Valencia Technologies Corporation$536
- Procept Biorobotics Corporation$333
- Calyxo, Inc.$286
- plus $2K from 14 others
Across 25 payments — averaging $6583.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Uromedica, Incorporated$126K
- Boston Scientific$25K
- Ipsen Innovation$14K
What the payments were for
- Travel & lodging$7,34962%
- Food & beverage$4,44137%
- Education$951%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Uromedica, Incorporated | 5 | $7,099 |
| Teleflex LLC | 2 | $957 |
| Boston Scientific | 10 | $565 |
| Valencia Technologies Corporation | 6 | $536 |
| Procept Biorobotics Corporation | 3 | $333 |
| Calyxo, Inc. | 2 | $286 |
| SWAN Valley Medical Incorporated | 2 | $275 |
| Medtronic(2 entities) | 6 | $262 |
| Coloplast | 2 | $262 |
| Innovation Technologies Inc | 5 | $260 |
| Arthrex | 4 | $241 |
| Caldera Medical, Inc | 2 | $226 |
| Axonics, Inc. | 2 | $119 |
| Laborie Medical Technologies Corp. | 2 | $118 |
| Astellas Pharma US Inc | 1 | $95 |
| AbbVie(2 entities) | 4 | $91 |
| Blue Earth Diagnostics | 1 | $68 |
| Cook Medical LLC | 2 | $62 |
| Intuitive Surgical | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProACT$7,005
- Barrigel$957
- UroLift$957
- eCoin Device Kit$342
- CVAC Aspiration System$286
- AquaBeam Robotic System$274
- Desara$181
- TITAN$181
- Irrisept$123
- AMS 800 Artificial Urinary Sphincter$120
- Axonics r-SNM System$101
- Signia$101
How this compares
$11,901 in reported general payments places this provider in the 80th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 174 | $175,979 |
| PremarinEstrogens, Conjugated | 13 | $5,766 |
| Methenamine Hippurate | 46 | $2,948 |
| Oxybutynin Chloride ErOxybutynin Chloride | 114 | $2,805 |
| Estradiol | 23 | $2,531 |
| Solifenacin Succinate | 39 | $1,273 |
| Tamsulosin Hcl | 70 | $827 |
| Potassium Citrate ErPotassium Citrate | 15 | $458 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $335 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $319 |
| Finasteride | 24 | $257 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 66 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $138 |
| Levofloxacin | 32 | $77 |
| Oxybutynin Chloride | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $95 | $175,979174 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 225 urology providers in Colorado.
Other urology in Aurora
- Janet KukrejaAurora$39K
- Kirk RedgerAurora$24K
- David StraussAurora$16K
- Kerri ThurmonAurora$16K
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
- Suzanne MerrillLone Tree$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.